Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Zemuron

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The danger of anaphylaxis, a rare but life threatening complication of general anesthesia (GA) can be summarized in two: 1… Expand
2010
2010
Rocuronium, a non-depolarizing neuromuscular blocking agent, was released to the market in the United States in 1994 and marketed… Expand
  • figure 1
2005
2005
It’s “nurse Newbie’s” first day on the job and Doctor-I-have-the-worsthandwriting-in-the-world leaves an order to administer Z… Expand
2005
2005
remember that’s only the ones patients choose to fill). That’s 3 billion-plus chances for error—AND for callbacks from the… Expand
Review
1996
Review
1996
Abstract : Currently, a variety of agents are available to anesthesia providers for induction and intubation for general… Expand
1994
1994
Rocuronium bromide (Zemuron) is a new steroidal nondepolarizing neuromuscular blocking drug. We were interested in determining… Expand